Stockreport

GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review [Yahoo! Finance]

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF for its investigational, first-in-class oral antibiotic, gepotidacin for treating uncomplicated urinary tract infections (uUTIs) in female adults and adolescents. With [Read more]